版本:
中国

BRIEF-Xbiotech says received negative opinion for its lead product candidate in Europe

May 18 Xbiotech Inc

* Xbiotech - received negative opinion from EMA CHMP for marketing authorization application for its lead product candidate in Europe

* Xbiotech - co plans to promptly notify EMA of its request for a re-examination and will have 60 days to submit its grounds for appeal - SEC filing Source text for Eikon: (bit.ly/2q153RU) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐